美国FDA药品数据库-药物在线

商品名	申请号	产品号	申请类型	活性成分	剂型/给药途径	规格/剂量	RLD	RS	申请号原始批准/暂定批准日期	产品号批准日期	申请人	市场状态
METFORMIN HYDROCHLORIDE	209303	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	500MG	No	No	2018/03/19	2018/03/19	ALIGNSCIENCE PHARMA	Prescription
METFORMIN HYDROCHLORIDE	209882	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	500MG	No	No	2018/08/27	2018/08/27	LAURUS	Prescription
METFORMIN HYDROCHLORIDE	209882	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	850MG	No	No	2018/08/27	2018/08/27	LAURUS	Prescription
METFORMIN HYDROCHLORIDE	209882	003	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	1GM	No	No	2018/08/27	2018/08/27	LAURUS	Prescription
METFORMIN HYDROCHLORIDE	208880	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	500MG	No	No	2018/09/10	2018/09/10	PRINSTON INC	Prescription
METFORMIN HYDROCHLORIDE	208880	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	750MG	No	No	2018/09/10	2018/09/10	PRINSTON INC	Prescription
METFORMIN HYDROCHLORIDE	211052	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	500MG	No	No	2018/09/24	2018/09/24	YICHANG HUMANWELL	Prescription
METFORMIN HYDROCHLORIDE	211052	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	750MG	No	No	2018/09/24	2018/09/24	YICHANG HUMANWELL	Prescription
METFORMIN HYDROCHLORIDE	208999	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	500MG	No	No	2018/10/12	2018/10/12	SUNSHINE	Discontinued
METFORMIN HYDROCHLORIDE	208999	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	850MG	No	No	2018/10/12	2018/10/12	SUNSHINE	Discontinued
METFORMIN HYDROCHLORIDE	208999	003	ANDA	METFORMIN HYDROCHLORIDE	TABLET;ORAL	1GM	No	No	2018/10/12	2018/10/12	SUNSHINE	Discontinued
METFORMIN HYDROCHLORIDE	206145	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	500MG	No	No	2018/10/22	2018/10/22	ALKEM LABS LTD	Prescription
METFORMIN HYDROCHLORIDE	206145	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	750MG	No	Yes	2018/10/22	2018/10/22	ALKEM LABS LTD	Prescription
LINAGLIPTIN; METFORMIN HYDROCHLORIDE	208430	001	ANDA	LINAGLIPTIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	2.5MG;500MG	No	No	2018/11/01 (TA)	--	MYLAN PHARMS INC	None (Tentative Approval)
LINAGLIPTIN; METFORMIN HYDROCHLORIDE	208430	002	ANDA	LINAGLIPTIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	2.5MG;850MG	No	No	2018/11/01 (TA)	--	MYLAN PHARMS INC	None (Tentative Approval)
LINAGLIPTIN; METFORMIN HYDROCHLORIDE	208430	003	ANDA	LINAGLIPTIN;METFORMIN HYDROCHLORIDE	TABLET;ORAL	2.5MG;1GM	No	No	2018/11/01 (TA)	--	MYLAN PHARMS INC	None (Tentative Approval)
METFORMIN HYDROCHLORIDE	209674	001	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	500MG	No	No	2018/11/02	2018/11/02	NOVAST LABS	Prescription
METFORMIN HYDROCHLORIDE	209674	002	ANDA	METFORMIN HYDROCHLORIDE	TABLET, EXTENDED RELEASE;ORAL	1GM	No	No	2018/11/02	2018/11/02	NOVAST LABS	Prescription
ALOGLIPTIN; METFORMIN HYDROCHLORIDE	210160	001	ANDA	ALOGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET;ORAL	EQ 12.5MG BASE;500MG	No	No	2018/12/19 (TA)	--	TORRENT PHARMS LTD	None (Tentative Approval)
ALOGLIPTIN; METFORMIN HYDROCHLORIDE	210160	002	ANDA	ALOGLIPTIN; METFORMIN HYDROCHLORIDE	TABLET;ORAL	EQ 12.5MG BASE;1GM	No	No	2018/12/19 (TA)	--	TORRENT PHARMS LTD	None (Tentative Approval)